Antacid Injection Recalled

A customer report about unrefrigerated product has prompted HF Acquisition Co. to recall a single lot of famotidine injection, according to the July 29, 2020, US Food and Drug Administration (FDA) Enforcement Report. 

The recall affects famotidine injection, 20 mg/2 mL, 2-mL single-dose vials (NDC 63323-739-12) from lot 6122639 (Exp. 8/21). The vials were distributed to a consignee in Connecticut. 

HF Acquisition Co. voluntarily initiated the recall June 17, 2020. On July 21, 2020, the FDA designated the recall Class III. Under the recall classification, use of the affected product is not likely to cause harm.

Famotidine injections are used to treat hospitalized patients for conditions caused by too much stomach acid or to treat ulcers.

—Jolynn Tumolo